Corporate and Finance


Arnold & Porter's Corporate and Finance practice represents:

  • private equity firms and public and private corporations in all manner of mergers, acquisitions, and dispositions;
  • sovereign nations and sub-sovereign and quasi-governmental issuers in capital markets and financing transactions;
  • corporate issuers and underwriters in registered and unregistered issuances of equity and debt, ranging from emerging companies in venture capital financings and IPOs to large-cap public companies in SEC-registered offerings and continuing reporting and compliance;
  • banks and non-bank lenders and borrowers in secured loan transactions; and
  • hedge funds, private equity funds, and other investment vehicles in their formation, product development, and regulatory compliance.

Our Corporate and Finance practice is closely integrated with other leading practice groups at the firm, thereby providing a full-service solution for our clients, with lawyers who have a deep understanding of the industry in which they operate. We believe this is a fundamental differentiator of Arnold & Porter.

For example, our Corporate and Finance group practitioners have developed broad experience in the following industries, having worked closely over many years with our industry experts in other practice groups:

  • Federal Government Services, where we have an industry leading government contracts and national security practice;
  • Financial Institutions, where our transactional practice works closely with our leading practitioners in financial services regulation, compliance, and enforcement;
  • Life Sciences, where we have a leading FDA practice that provides unique perspective on the regulatory environment for biotechnology, pharmaceutical, and medical device companies;
  • Healthcare, where we have leading capabilities in Medicare reimbursement and regulatory compliance issues;
  • Energy, where our deal lawyers work closely with our energy regulatory lawyers and Environmental practice, which provides insights on industry trends and other government initiatives impacting the energy industry;
  • Information Technology, where our Intellectual Property practice group represents leading software and technology companies in patent and copyright litigation, and our IP transactional team provides cutting-edge experience in licensing, joint ventures, and commercial transactions.


Legal Considerations in a Negative Interest Rate Environment
Coronavirus: Corporate and Finance Advisory
Small Business Loan Relief From CARES Act
Coronavirus: Multipractice Advisory
SEC Staff Expresses Its Views on COVID-19 Disclosures as Earnings Season Commences; Exemptive Relief Extended for Filings with Deadlines on or Before July 1, 2020
Coronavirus: Corporate Governance, SEC Reporting and Compliance Advisory
Coronavirus Legislative Update: The CARES Act Becomes Law
Coronavirus: Legislative and Public Policy Advisory
Managing Financial Distress in the Coronavirus Crisis—Reconsidering Fiduciary Duties and Liability Management Transactions
Coronavirus: Corporate and Finance, Bankruptcy and Restructuring Webinar


Chambers FinTech
Band 5: USA (2020)
Chambers Global
Capital Markets (Latin America-wide) (2020)
Capital Markets: Securitisation (USA) (2020)
Banking & Finance (Latin America-wide) (2020)
Capital Markets: Debt & Equity (USA) (2017)
Corporate/M&A (China) (2017)
Chambers USA
Corporate/M&A and Private Equity (DC) (2019)
Corporate/M&A: Highly Regarded (New York) (2019)
Capital Markets: Securitization (Nationwide) (2019)
Corporate/M&A: Highly Regarded (Nationwide) (2018)

Email Disclaimer